DE10294405D2 - Use of Interfernon beta for the treatment of systemic lupus erythematosus - Google Patents

Use of Interfernon beta for the treatment of systemic lupus erythematosus

Info

Publication number
DE10294405D2
DE10294405D2 DE10294405T DE10294405T DE10294405D2 DE 10294405 D2 DE10294405 D2 DE 10294405D2 DE 10294405 T DE10294405 T DE 10294405T DE 10294405 T DE10294405 T DE 10294405T DE 10294405 D2 DE10294405 D2 DE 10294405D2
Authority
DE
Germany
Prior art keywords
interfernon
beta
treatment
lupus erythematosus
systemic lupus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE10294405T
Other languages
German (de)
Inventor
Andreas Schwarting
Peter R Galle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE10294405T priority Critical patent/DE10294405D2/en
Application granted granted Critical
Publication of DE10294405D2 publication Critical patent/DE10294405D2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
DE10294405T 2001-09-29 2002-09-27 Use of Interfernon beta for the treatment of systemic lupus erythematosus Expired - Fee Related DE10294405D2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE10294405T DE10294405D2 (en) 2001-09-29 2002-09-27 Use of Interfernon beta for the treatment of systemic lupus erythematosus

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10148417A DE10148417A1 (en) 2001-09-29 2001-09-29 Use of interferon-ß for the therapy of systemic lupus erythematosus
PCT/DE2002/003669 WO2003028753A1 (en) 2001-09-29 2002-09-27 USE OF INTERFERON β IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATODES
DE10294405T DE10294405D2 (en) 2001-09-29 2002-09-27 Use of Interfernon beta for the treatment of systemic lupus erythematosus

Publications (1)

Publication Number Publication Date
DE10294405D2 true DE10294405D2 (en) 2005-02-17

Family

ID=7700992

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10148417A Withdrawn DE10148417A1 (en) 2001-09-29 2001-09-29 Use of interferon-ß for the therapy of systemic lupus erythematosus
DE10294405T Expired - Fee Related DE10294405D2 (en) 2001-09-29 2002-09-27 Use of Interfernon beta for the treatment of systemic lupus erythematosus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10148417A Withdrawn DE10148417A1 (en) 2001-09-29 2001-09-29 Use of interferon-ß for the therapy of systemic lupus erythematosus

Country Status (2)

Country Link
DE (2) DE10148417A1 (en)
WO (1) WO2003028753A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0707208D0 (en) * 2007-04-13 2007-05-23 Istituto Superiore Di Sanito Novel disease treatments

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1320905C (en) * 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
US5780021A (en) * 1993-03-05 1998-07-14 Georgetown University Method for treating type 1 diabetes using α-interferon and/or β-i
AU780270B2 (en) * 2000-02-23 2005-03-10 Association Francaise Contre Les Myopathies Treatment of immune diseases

Also Published As

Publication number Publication date
DE10148417A1 (en) 2003-04-17
WO2003028753A1 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
DK1223927T3 (en) Use of retigabine for the treatment of neuropathic pain
ATE246500T1 (en) USE OF ANTI-MICROTUBULAR AGENTS FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY TRACT
DK1028954T3 (en) Substituted imidazoles suitable for the treatment of inflammatory diseases
DE60202267D1 (en) OCCIPUTPLATE AND SYSTEM FOR STABILIZING THE SPINE
DE60114580D1 (en) USE OF CYANOCHINOLINES FOR THE TREATMENT OR INHIBITION OF THICK DARMPOLYPES
DE69903543T2 (en) FORMULATIONS FOR THE TREATMENT OF REFLUX GENTLE EYES
DK1562932T3 (en) 4 tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
ATE271038T1 (en) 4-PHENYLPIPERIDINE FOR THE TREATMENT OF PRUTITIC SKIN DISEASES
DE50014041D1 (en) USE OF EPINASTINE FOR THE TREATMENT OF ALLERGIC RHINITIS / CONJUNCTIVITIS
DE60227718D1 (en) Use of 2-fuoro-3-ketoesters for the preparation of 3-fuoro-6,7,8,9-tetrahydro-4H-pyrimido-1,2-a-pyrimidin-4-ones
ATE290786T1 (en) FUNGICIDAL COMPOSITION AND USE OF THIS COMPOSITION FOR CONTROLLING PLANT DISEASES
DE60030861D1 (en) Use of escitalopram for the treatment of generalized anxiety
DE60328494D1 (en) IMPROVED SYSTEM FOR THE TREATMENT OF STRESS-RELATED HARNINE INCONTINENCE
EE200200632A (en) Preparations containing glucocorticoids for the treatment of bronchopulmonary disorders
ID27214A (en) TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
DE50114605D1 (en) NO-THIEN-2-YL-VINEGAR DERIVATIVES AND THEIR USE FOR THE TREATMENT OF MIGRAINE BZW. PAIN
DE50209948D1 (en) Use of scopinester derivatives for the manufacture of medicaments
DE60117122D1 (en) USE OF MIRTAZAPIN FOR THE TREATMENT OF SLEEP DISORDERS
ATE230741T1 (en) 3-TETRAHYDROPYRIDINE-4-YL-INDOLE FOR THE TREATMENT OF PSYCHOTIC DISORDERS
DE50212649D1 (en) USE OF DESOXYPEGANINE FOR THE TREATMENT OF CLINICAL DEPRESSION
DE10294405D2 (en) Use of Interfernon beta for the treatment of systemic lupus erythematosus
NO20010390D0 (en) Treatment of anxiety disorders
FI980092A0 (en) Regulation and order of the harvester
DE60005685D1 (en) OXAZINOCARBAZOLE FOR THE TREATMENT OF CNS DISEASES
DE50011084D1 (en) USE OF AZENES FOR THE PREVENTION OF RADIUS-INDUCED SKIN CANCER

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee